Back

Welcome and introduction.

1 July 2021 (11:20 - 11:25)
Organised by:
Congress Presentation Part of: Management of Arrhythmias in Cardiac Dysfunction Patients: ESC Guidelines Update & New Approaches with Landiolol Pharmacotherapy Open Access Heart Failure 2021

4 More presentations in this session

Presentation thumbnail
Intravenous landiolol, a novel β (1)-adrenergic blocker for patients with cardiac dysfunction and atrial fibrillation.
Professor H. Puererfellner (Linz, AT)
Video
Presentation thumbnail
Questions and answers.
Presentation thumbnail
Management of Atrial Fibrillation in patients with cardiac dysfunction. The 2020 ESC Guidelines and the addition of Landiolol.
Professor Z. Fras (Ljubljana, SI)
Video
Presentation thumbnail
Questions & answers.

Access the full session

Session thumbnail
Management of Arrhythmias in Cardiac Dysfunction Patients: ESC Guidelines Update & New Approaches with Landiolol
Video

The Event

Event poster

Heart Failure 2021

1 July 2021 11:20 CET
You may be interested in
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023
thumbnail
Congress Session
Acute heart failure therapies: from clinical trials to clinical practice

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources